Amplion Blog European Emerging Pharma Orgs Advance Innovative Oncology Pipelines

Exciting oncology research is underway at several emerging European biopharmaceutical firms. Advances in cancer immunotherapies, antibody-drug conjugates, and combination therapies are highlighted in recent disclosures from these companies targeting both solid tumors and hematological malignancies. Adaptimmune Drives TCR and Cell Therapy Forward UK-based Adaptimmune has presented positive data on its SPEAR T-cell platform targeting NY-ESO [...]The post European Emerging Pharma Orgs Advance Innovative Oncology Pipelines appeared first on Amplion.